Literature DB >> 15649237

Exercise-induced ventricular arrhythmias and cardiovascular death.

James Beckerman1, Anima Mathur, Stephen Stahr, Jonathan Myers, Sung Chun, Victor Froelicher.   

Abstract

BACKGROUND: Exercise-induced ventricular arrhythmias (EIVA) are frequently observed during exercise testing. However, the clinical guidelines do not specify their significance and so we examined this issue in our population.
METHODS: A retrospective analysis of prospectively collected data was performed on 5754 consecutive male veterans referred for exercise testing at two university-affiliated Veterans Affairs Medical Centers. Exercise test responses were recorded and cardiovascular mortality was assessed after a mean follow-up of 6 +/- 4 years. EIVA were defined as frequent premature ventricular complexes (PVCs) constituting more than 10% of all ventricular depolarizations during any 30-second ECG recording, or a run of three or more consecutive PVCs during the exercise test or recovery.
RESULTS: EIVA occurred in 426 patients (7.4%). There were 550 (10.6%) cardiovascular deaths during follow-up. Seventy two (17%) patients with EIVA died of cardiovascular causes, whereas 478 (9.0%) of patients without EIVA died of cardiovascular causes (P < 0.001). Patients with EIVA had a higher prevalence of cardiovascular disease, resting PVCs, resting ST depression, and ischemia during exercise than patients without EIVA. In a Cox hazards model adjusted for age, cardiovascular disease, exercise-induced ischemia, ECG abnormalities, exercise capacity and risk factors, EIVA was significantly associated with time to cardiovascular death. The combination of both resting PVCs and EIVA was associated with the highest hazard ratio.
CONCLUSIONS: EIVA are independent predictors of cardiovascular mortality after adjusting for other clinical and exercise test variables; combination with resting PVCs carries the highest risk.

Entities:  

Mesh:

Year:  2005        PMID: 15649237      PMCID: PMC6932206          DOI: 10.1111/j.1542-474X.2005.00599.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  26 in total

1.  Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations.

Authors:  X Jouven; M Zureik; M Desnos; D Courbon; P Ducimetière
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

2.  Cardiac arrhythmias observed during maximal treadmill exercise testing in clinically normal men.

Authors:  P L McHenry; C Fisch; J W Jordan; B R Corya
Journal:  Am J Cardiol       Date:  1972-03       Impact factor: 2.778

3.  Predictive implications of ventricular premature contractions associated with treadmill stress testing.

Authors:  J A Udall; M H Ellestad
Journal:  Circulation       Date:  1977-12       Impact factor: 29.690

4.  Prevalence and long-term significance of exercise-induced frequent or repetitive ventricular ectopic beats in apparently healthy volunteers.

Authors:  M J Busby; E A Shefrin; J L Fleg
Journal:  J Am Coll Cardiol       Date:  1989-12       Impact factor: 24.094

5.  "Recovery only" ST-segment depression and the predictive accuracy of the exercise test.

Authors:  B Lachterman; K G Lehmann; D Abrahamson; V F Froelicher
Journal:  Ann Intern Med       Date:  1990-01-01       Impact factor: 25.391

6.  Ventricular arrhythmias during exercise testing: mechanism, response to coronary bypass surgery and prognostic significance.

Authors:  D A Weiner; S R Levine; M D Klein; T J Ryan
Journal:  Am J Cardiol       Date:  1984-06-01       Impact factor: 2.778

7.  Exercise-induced ventricular arrhythmias in patients with healed myocardial infarction.

Authors:  G Casella; P C Pavesi; P Sangiorgio; A Rubboli; D Bracchetti
Journal:  Int J Cardiol       Date:  1993-07-15       Impact factor: 4.164

8.  Prevalence and prognostic value of exercise-induced ventricular arrhythmias.

Authors:  Sara Partington; Jonathan Myers; Shaun Cho; Victor Froelicher; Sung Chun
Journal:  Am Heart J       Date:  2003-01       Impact factor: 4.749

9.  A nomogram to predict exercise capacity from a specific activity questionnaire and clinical data.

Authors:  J Myers; D Do; W Herbert; P Ribisl; V F Froelicher
Journal:  Am J Cardiol       Date:  1994-03-15       Impact factor: 2.778

10.  Clinical relevance of exercise-induced ventricular arrhythmias in suspected coronary artery disease.

Authors:  M A Marieb; G A Beller; R S Gibson; B B Lerman; S Kaul
Journal:  Am J Cardiol       Date:  1990-07-15       Impact factor: 2.778

View more
  6 in total

Review 1.  The year 2005 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

Review 2.  Non-invasive risk stratification: prognostic implications of exercise testing.

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-03

3.  Prognostic significance of exercise-induced premature ventricular complexes: a systematic review and meta-analysis of observational studies.

Authors:  Victor Lee; Dhanuka Perera; Pier Lambiase
Journal:  Heart Asia       Date:  2017-01-04

4.  Clinical Significance of Ventricular Premature Contraction Provoked by the Treadmill Test.

Authors:  Min-Jung Bak; Hee-Jin Kwon; Ji-Hoon Choi; Seung-Jung Park; June-Soo Kim; Young-Keun On; Kyoung-Min Park
Journal:  Medicina (Kaunas)       Date:  2022-04-18       Impact factor: 2.948

5.  Ventricular arrhythmias not meeting criteria for terminating cardiopulmonary exercise testing stratify prognosis and disease severity in heart failure of preserved, midrange, and reduced ejection fraction.

Authors:  Dejana Popovic; Ross Arena; Djordje Jakovljevic; Arsen Ristic; Marco Guazzi
Journal:  Clin Cardiol       Date:  2020-04-09       Impact factor: 2.882

6.  Prognostic implications of structural heart disease and premature ventricular contractions in recovery of exercise.

Authors:  Thomas Lindow; Magnus Ekström; Lars Brudin; Kristofer Hedman; Martin Ugander
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.